NO951350L - Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides - Google Patents

Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides

Info

Publication number
NO951350L
NO951350L NO951350A NO951350A NO951350L NO 951350 L NO951350 L NO 951350L NO 951350 A NO951350 A NO 951350A NO 951350 A NO951350 A NO 951350A NO 951350 L NO951350 L NO 951350L
Authority
NO
Norway
Prior art keywords
oxindole
carboxamides
substituted
pharmaceutical preparations
preparations containing
Prior art date
Application number
NO951350A
Other languages
Norwegian (no)
Other versions
NO951350D0 (en
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO951350D0 publication Critical patent/NO951350D0/en
Publication of NO951350L publication Critical patent/NO951350L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives et farmasøytisk preparat som omfatter: (A) minst ett triglycerid eller en propylenglykol-diester av fraksjonerte kokosolje-fettsyrer; og (B) minst en forbindelse med.formel (I) (D hvor R!, R2 og R3 uavhengig av hverandre, er hydrogen, fluor, brom eller klor, eller et farmasøytisk akseptabelt salt derav.A pharmaceutical composition is disclosed which comprises: (A) at least one triglyceride or propylene glycol diester of fractionated coconut oil fatty acids; and (B) at least one compound of formula (I) (D wherein R 1, R 2 and R 3 are independently hydrogen, fluorine, bromine or chlorine, or a pharmaceutically acceptable salt thereof.

NO951350A 1992-10-07 1995-04-06 Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides NO951350L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07
PCT/US1993/008063 WO1994007488A1 (en) 1992-10-07 1993-09-02 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO951350D0 NO951350D0 (en) 1995-04-06
NO951350L true NO951350L (en) 1995-06-06

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951350A NO951350L (en) 1992-10-07 1995-04-06 Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides

Country Status (21)

Country Link
EP (1) EP0662831A1 (en)
JP (1) JP2721042B2 (en)
KR (1) KR950703338A (en)
CN (1) CN1089138A (en)
AU (1) AU676200B2 (en)
BR (1) BR9307182A (en)
CA (1) CA2146448A1 (en)
CZ (1) CZ282702B6 (en)
EG (1) EG20289A (en)
FI (1) FI934387A (en)
HU (1) HUT68533A (en)
IL (1) IL107122A (en)
MX (1) MX9306222A (en)
MY (1) MY109680A (en)
NO (1) NO951350L (en)
NZ (1) NZ256164A (en)
PL (1) PL174170B1 (en)
RU (1) RU2119353C1 (en)
TW (1) TW438798B (en)
WO (1) WO1994007488A1 (en)
ZA (1) ZA937405B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (en) * 1993-08-26 1996-06-16 Pfizer PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
WO1996033701A1 (en) * 1995-04-24 1996-10-31 Pfizer Inc. Inhibiting photodecomposition of 3-substituted-2-oxindoles
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
JP5869764B2 (en) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 Capsule filling composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
EP0620728B1 (en) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation of tablets of increased strength

Also Published As

Publication number Publication date
AU676200B2 (en) 1997-03-06
JP2721042B2 (en) 1998-03-04
HUT68533A (en) 1995-04-27
FI934387A (en) 1994-04-08
ZA937405B (en) 1995-04-06
MX9306222A (en) 1994-04-29
IL107122A (en) 1998-08-16
CZ282702B6 (en) 1997-09-17
MY109680A (en) 1997-04-30
CN1089138A (en) 1994-07-13
AU4839293A (en) 1994-04-26
RU2119353C1 (en) 1998-09-27
IL107122A0 (en) 1993-12-28
KR950703338A (en) 1995-09-20
NZ256164A (en) 1997-03-24
WO1994007488A1 (en) 1994-04-14
NO951350D0 (en) 1995-04-06
TW438798B (en) 2001-06-07
CZ87895A3 (en) 1995-10-18
EG20289A (en) 1998-07-30
EP0662831A1 (en) 1995-07-19
CA2146448A1 (en) 1994-04-14
JPH07507809A (en) 1995-08-31
PL308307A1 (en) 1995-07-24
HU9302821D0 (en) 1993-12-28
BR9307182A (en) 1999-03-30
FI934387A0 (en) 1993-10-06
PL174170B1 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
SE8404019L (en) Ophthalmic anti-inflammatory agents
ES2081187T3 (en) NEW NAFTIL-ALQUIL-AMINAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
NO863823L (en) 1,5-BENZOTHIAZEPINE DERIVATIVES USED AS BASIC MATERIALS IN THE PREPARATION OF NEW, THERAPEUTICALLY ACTIVE 8-CHLORO-1,5-BENZOTHIAZEPINE DERIVATIVES, AND PROCEDURES IN THEIR PREPARATION.
DK0580502T3 (en) 3- (hydroxybenzylidenyl) -indolin-2-ones and pharmaceutical compositions containing them
CH692199A8 (en) PYRIDIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
YU20197A (en) Vitamine d3 analogues, pharmaceutical compositions containing them as an active matter and the use thereof in the production of pharmaceutical compositions
NO163331C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 6,7-DISUBSTITUTED 1-CYCLEOPROPYL-1,4-DIHYDRO-4-OXO-1,8-NAFTYRIDINE-3-CARBOXYL ACIDS.
EA200200489A1 (en) NEW COMPOUNDS OF BENZOTHIADIAZINE, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
NO951350L (en) Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides
WO1994014833A3 (en) Substituted 6-azaandrostenones
NO161620C (en) ANALOGY PROCEDURE TE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 8-ALKYLTIO-2-PIPERAZINO-PYRIMIDO (5,4-D) PYRIMIDINE DERIVATIVES.
IL74800A (en) Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DK283984D0 (en) BENZODIAZEPINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
FI871637A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV 1,5-BENZOTIAZEPINDERIVAT.
ES2077473T3 (en) NEW THIOCHROMANIC COMPOUNDS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NO170580C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS
DK681187A (en) COMPOUND WHICH ABSORPS ULTRAVIOLET LIGHT AND PREPARATION CONTAINING SAME
AU4004589A (en) Cleansing composition for topical disinfection
ES2117003T3 (en) OLIGOPEPTIDICAL DERIVATIVES OF HIPOXANTINA GIVEN WITH IMMUNOMODULATING ACTIVITY, AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2076106A1 (en) Pharmaceutical compositions based on 3-substituted 2-oxindol-1-carboxamides.
NO933691L (en) Thiocarbamate sulfoxide composition for abstinence from ingestion of ethanol
SE8204791D0 (en) PROCESS FOR PREPARING ALKOXY-VINCAMINIC ACID ESTERS AND ALKOXY-APOVINCAMINIC ACID ESTERS
DK30284A (en) pyrrolidines
ES2123038T3 (en) NEW DERIVATIVES PIRROLO-TIENO-PIRAZINICOS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
EA199700299A1 (en) NITROGEN COMPOUNDS WITH ANTI-FIBER (ANTIMICOUS) ACTIVITY APPLICABLE FOR THE TREATMENT OF PEOPLE AND IN VETERINARY